pmid	doi	year	title	Hugo_Symbol
34753803	10.1158/1541-7786.MCR-21-0208	2022	MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer.	BCL10
34783281	10.1080/10428194.2021.1999444	2022	Targeting MALT1 for the treatment of diffuse large B-cell lymphoma.	BCL10
34906687	10.1016/j.fsi.2021.12.009	2022	BCL10 regulates the production of proinflammatory cytokines by activating MAPK-NF-κB/Rel signaling pathway in oysters.	BCL10
35099607	10.1007/s00018-022-04154-z	2022	A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells.	BCL10
35192832	10.1016/j.scitotenv.2022.153990	2022	Effects of gestational exposure to bisphenol A on the hepatic transcriptome and lipidome of rat dams: Intergenerational comparison of effects in the offspring.	BCL10
35218741	10.1016/j.bcp.2022.114977	2022	Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases.	BCL10
35230873	10.1126/scisignal.abk3083	2022	Phosphorylation of serine-893 in CARD11 suppresses the formation and activity of the CARD11-BCL10-MALT1 complex in T and B cells.	BCL10
35255409	10.1016/j.jbior.2022.100890	2022	CARD11 signaling in regulatory T cell development and function.	BCL10
35406516	10.3390/cancers14071742	2022	Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment.	BCL10
35411950	10.1002/cbf.3702	2022	USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma.	BCL10
35540095	10.1016/j.jacbts.2022.02.004	2022	CARD9-Mediated Signaling and Cardiovascular Diseases.	BCL10
35600392	10.3389/fonc.2022.881801	2022	SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer.	BCL10
35658124	10.1158/2159-8290.CD-21-1566	2022	BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.	BCL10
35727133	10.7554/eLife.79826	2022	A nucleation barrier spring-loads the CBM signalosome for binary activation.	BCL10
35750252	10.1016/j.clim.2022.109067	2022	BCL10 loss-of-function novel mutation leading to atypical severe combined immunodeficiency.	BCL10
35929131	10.1158/2159-8290.CD-22-0614	2022	BCL10 Mutants: Architects of Oncogenic Signaling Provide a Blueprint for Precision Medicine.	BCL10
35981904	10.1016/j.jaci.2022.06.023	2022	The role of the CBM complex in allergic inflammation and disease.	BCL10
36094731	10.1007/s12104-022-10105-3	2022	Assignment of IVL-Methyl side chain of the ligand-free monomeric human MALT1 paracaspase-IgL<sub>3</sub> domain in solution.	BCL10
31595055	10.1038/s41423-019-0297-y	2021	Bcl10 is required for the development and suppressive function of Foxp3<sup>+</sup> regulatory T cells.	BCL10
32790937	10.1111/febs.15522	2021	Defining the combinatorial space of PKC::CARD-CC signal transduction nodes.	BCL10
32838054	10.1016/j.coemr.2020.07.011	2021	Subcellular hot spots of GPCR signaling promote vascular inflammation.	BCL10
32855441	10.1038/s41379-020-00660-2	2021	Deciphering the genetic landscape of pulmonary lymphomas.	BCL10
32927162	10.1016/j.ecoenv.2020.111272	2021	Augmented autophagy suppresses thymocytes development via Bcl10/p-p65 pathway in prenatal nicotine exposed fetal mice.	BCL10
33419765	10.4049/jimmunol.2001031	2021	Intrinsic Abnormalities of Keratinocytes Initiate Skin Inflammation through the IL-23/T17 Axis in a MALT1-Dependent Manner.	BCL10
33640899	10.1038/s41392-021-00477-8	2021	TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO.	BCL10
33777778	10.3389/fonc.2021.628807	2021	Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.	BCL10
33872653	10.1016/j.jaci.2021.04.006	2021	Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency.	BCL10
33941870	10.1038/s41418-021-00787-y	2021	USP12 promotes CD4<sup>+</sup> T cell responses through deubiquitinating and stabilizing BCL10.	BCL10
34014917	10.1371/journal.pcbi.1007986	2021	Signaling through polymerization and degradation: Analysis and simulations of T cell activation mediated by Bcl10.	BCL10
34192836	10.1515/hsz-2021-0250	2021	The paracaspase MALT1 in psoriasis.	BCL10
34236636	10.1007/978-1-0716-1669-7_8	2021	Methods to Study CARD11-BCL10-MALT1 Dependent Canonical NF-κB Activation in Jurkat T Cells.	BCL10
34412631	10.1186/s12935-021-02143-z	2021	Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling.	BCL10
34481211	10.1016/j.prp.2021.153593	2021	Bcl-10, trypsin and synaptophysin helps recognize acinar cell and mixed acinar neuroendocrine cell carcinoma of the pancreas on both preoperative cytological samples and needle biopsy specimens.	BCL10
34499781	10.1111/pin.13164	2021	Primary pure pancreatic-type acinar cell carcinoma of the stomach.	BCL10
34826258	10.1126/sciimmunol.abi4425	2021	Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation.	BCL10
34868072	10.3389/fimmu.2021.786572	2021	Clinical and Immunological Features of Human BCL10 Deficiency.	BCL10
34879060	10.1371/journal.pntd.0010029	2021	Deep resequencing identifies candidate functional genes in leprosy GWAS loci.	BCL10
34928543	10.1002/iub.2581	2021	BCL10 correlates with bad prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.	BCL10
31241148	10.1093/cvr/cvz169	2020	B-cell lymphoma/leukaemia 10 and angiotensin II-induced kidney injury.	BCL10
31751629	10.1016/j.dci.2019.103555	2020	The signaling relations between three adaptors of porcine C-type lectin receptor pathway.	BCL10
31757436	10.1016/j.pathol.2019.08.012	2020	Marginal zone B-cell lymphoma: lessons from Western and Eastern diagnostic approaches.	BCL10
31774199	10.15252/embj.2019102030	2020	Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.	BCL10
31808815	10.1093/cvr/cvz320	2020	A complex role for Bcl10 in kidney injury.	BCL10
31883669	10.1016/j.pathol.2019.09.014	2020	The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma.	BCL10
31961340	10.1172/JCI97040	2020	GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein.	BCL10
32008135	10.1007/s10875-020-00760-3	2020	Human BCL10 Deficiency due to Homozygosity for a Rare Allele.	BCL10
32012328	10.1002/hon.2718	2020	High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.	BCL10
32164050	10.4143/crt.2019.606	2020	Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.	BCL10
32179489	10.1016/j.cancergen.2020.02.005	2020	Integrating transcriptome-wide association study and copy number variation study identifies candidate genes and pathways for diffuse non-Hodgkin's lymphoma.	BCL10
32343482	10.15252/embr.201949237	2020	MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice.	BCL10
32388054	10.1016/j.cellimm.2020.104115	2020	TAK1 lessens the activity of the paracaspase MALT1 during T cell receptor signaling.	BCL10
32450431	10.1016/j.cellimm.2020.104133	2020	The LUBAC participates in lysophosphatidic acid-induced NF-κB activation.	BCL10
32574386	10.1111/ejh.13467	2020	MALT-1 as a novel therapeutic target for adult T-cell leukemia.	BCL10
32593012	10.1016/j.cellimm.2020.104147	2020	Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease.	BCL10
32683230	10.1016/j.jtemb.2020.126615	2020	Zinc homeostasis plays an important role in the prevention of obesity-induced cardiac inflammation, remodeling and dysfunction.	BCL10
32721634	10.1016/j.cellimm.2020.104158	2020	Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist.	BCL10
32768663	10.1016/j.cellimm.2020.104161	2020	Bcl10 is associated with actin dynamics at the T cell immune synapse.	BCL10
32771677	10.1016/j.cellimm.2020.104189	2020	The CBM complex: A growing multiplicity of cellular functions, regulatory mechanisms and connections to human disease.	BCL10
33052237	10.7150/thno.47533	2020	Targeting BCL10 by small peptides for the treatment of B cell lymphoma.	BCL10
33202260	10.1016/j.ajhg.2020.10.015	2020	Multiplexed Functional Assessment of Genetic Variants in CARD11.	BCL10
33297339	10.3390/nu12123755	2020	Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells.	BCL10
33329596	10.3389/fimmu.2020.601926	2020	Cellular and Mathematical Analyses of LUBAC Involvement in T Cell Receptor-Mediated NF-κB Activation Pathway.	BCL10
30514565	10.1016/j.cellimm.2018.11.001	2019	Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.	BCL10
30660642	10.1016/j.jaci.2018.12.1000	2019	Double-strand break repair through homologous recombination in autosomal-recessive BCL10 deficiency.	BCL10
30773504	10.5582/bst.2018.01291	2019	By regulating miR-182-5p/BCL10/CYCS, sufentanil reduces the apoptosis of umbilical cord mesenchymal stem cells caused by ropivacaine.	BCL10
31047877	10.1016/j.cca.2019.04.077	2019	BCL10 in cell survival after DNA damage.	BCL10
31060714	10.1016/j.jaci.2019.03.009	2019	Germline CBM-opathies: From immunodeficiency to atopy.	BCL10
31077220	10.1186/s13000-019-0815-3	2019	Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.	BCL10
31092922	10.1038/s41586-019-1215-2	2019	Targeting the CBM complex causes T<sub>reg</sub> cells to prime tumours for immune checkpoint therapy.	BCL10
31138793	10.1038/s41467-019-10203-2	2019	Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells.	BCL10
31178130	10.1016/j.bbrc.2019.06.004	2019	ZNF436 promotes tumor cell proliferation through transcriptional activation of BCL10 in glioma.	BCL10
31179345	10.1155/2019/9582714	2019	Distinct Effects of Carrageenan and High-Fat Consumption on the Mechanisms of Insulin Resistance in Nonobese and Obese Models of Type 2 Diabetes.	BCL10
31296852	10.1038/s41467-019-10953-z	2019	Structures of autoinhibited and polymerized forms of CARD9 reveal mechanisms of CARD9 and CARD11 activation.	BCL10
31391255	10.1074/jbc.RA119.009551	2019	Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling.	BCL10
31420608	10.1038/s41388-019-0958-4	2019	MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.	BCL10
31427546		2019	Characterisation of immunogenotypes of diffuse large B-cell lymphoma.	BCL10
31554683	10.1128/JVI.01499-19	2019	Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.	BCL10
31644910	10.1016/j.celrep.2019.09.040	2019	MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells.	BCL10
31658764	10.3390/ijms20205022	2019	B-Cell Activating Factor Enhances Hepatocyte-Driven Angiogenesis via B-Cell CLL/Lymphoma 10/Nuclear Factor-KappaB Signaling during Liver Regeneration.	BCL10
28886618	10.1111/cmi.12788	2018	Bcl10 synergistically links CEACAM3 and TLR-dependent inflammatory signalling.	BCL10
29259013	10.1158/0008-5472.CAN-17-1089	2018	The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.	BCL10
29289361	10.1016/j.blre.2017.12.001	2018	The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.	BCL10
29358699	10.1038/s41598-018-19822-z	2018	GSK3β modulates NF-κB activation and RelB degradation through site-specific phosphorylation of BCL10.	BCL10
29382759	10.1073/pnas.1721967115	2018	Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.	BCL10
29649481	10.1016/j.bbrc.2018.04.057	2018	Role of IκB kinase β in regulating the remodeling of the CARMA1-Bcl10-MALT1 complex.	BCL10
29765142	10.1038/s41379-018-0064-0	2018	Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.	BCL10
29881386	10.3389/fimmu.2018.01136	2018	Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions.	BCL10
29925955	10.1038/s41586-018-0290-0	2018	A multiprotein supercomplex controlling oncogenic signalling in lymphoma.	BCL10
29953499	10.1371/journal.pone.0199779	2018	Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.	BCL10
30022982	10.3389/fimmu.2018.01539	2018	BCL10 - Bridging CARDs to Immune Activation.	BCL10
30206119	10.1074/jbc.RA118.004821	2018	Picomolar zinc binding modulates formation of Bcl10-nucleating assemblies of the caspase recruitment domain (CARD) of CARD9.	BCL10
30214442	10.3389/fimmu.2018.01927	2018	Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling.	BCL10
30279415	10.1038/s41467-018-06573-8	2018	Molecular architecture and regulation of BCL10-MALT1 filaments.	BCL10
30283440	10.3389/fimmu.2018.02078	2018	The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.	BCL10
30283447	10.3389/fimmu.2018.02105	2018	Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease.	BCL10
30336982	10.1016/j.bbrc.2018.10.029	2018	MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.	BCL10
30386326	10.3389/fimmu.2018.02239	2018	Clinical and Genetic Heterogeneity of <i>CARD14</i> Mutations in Psoriatic Skin Disease.	BCL10
30401751	10.1182/bloodadvances.2018022962	2018	Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia.	BCL10
30429846	10.3389/fimmu.2018.02366	2018	A <i>CARD9</i> Founder Mutation Disrupts NF-κB Signaling by Inhibiting BCL10 and MALT1 Recruitment and Signalosome Formation.	BCL10
30446641	10.1038/s41467-018-07215-9	2018	Cellular metabolism constrains innate immune responses in early human ontogeny.	BCL10
30474008	10.3389/fonc.2018.00498	2018	Post-translational Modifications of the CARMA1-BCL10-MALT1 Complex in Lymphocytes and Activated B-Cell Like Subtype of Diffuse Large B-Cell Lymphoma.	BCL10
30515170	10.3389/fimmu.2018.02695	2018	BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation.	BCL10
30553470	10.1016/j.cancergen.2018.08.001	2018	Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases.	BCL10
26354285	10.1002/hon.2251	2017	Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma.	BCL10
27860444	10.1002/dc.23634	2017	Cytological findings and BCL10 expression in pancreatic acinar cell carcinoma: A Case Report.	BCL10
27864294	10.1182/blood-2016-05-718775	2017	B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma.	BCL10
27873317	10.1002/path.4852	2017	The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).	BCL10
27939769	10.1016/j.jid.2016.09.031	2017	CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.	BCL10
28052131	10.1371/journal.pone.0169026	2017	Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation.	BCL10
28158919	10.1111/jcmm.13050	2017	Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway.	BCL10
28163398	10.1155/2017/8634865	2017	<i>κ</i>-Carrageenan Enhances Lipopolysaccharide-Induced Interleukin-8 Secretion by Stimulating the Bcl10-NF-<i>κ</i>B Pathway in HT-29 Cells and Aggravates <i>C</i>. <i>freundii</i>-Induced Inflammation in Mice.	BCL10
28230860	10.1038/cddis.2017.51	2017	CARMA2sh and ULK2 control pathogen-associated molecular patterns recognition in human keratinocytes: psoriasis-linked CARMA2sh mutants escape ULK2 censorship.	BCL10
28288707	10.1016/j.beha.2016.09.002	2017	MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism.	BCL10
28672935	10.3892/etm.2017.4464	2017	Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer.	BCL10
28717989	10.1007/s13238-017-0441-3	2017	The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival.	BCL10
28765954	10.3892/mmr.2017.7116	2017	In vitro reconstitution of interactions in the CARD9 signalosome.	BCL10
29084984	10.1038/s41598-017-14102-8	2017	First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma.	BCL10
29194363	10.3390/ijms18122581	2017	The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14/CARMA2sh Signaling.	BCL10
29225710	10.1007/s12308-017-0302-2	2017	Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma.	BCL10
29340061	10.18632/oncotarget.22799	2017	Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets.	BCL10
26392569	10.1158/1541-7786.MCR-15-0229-T	2016	The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.	BCL10
26521038	10.1016/j.jaci.2015.09.016	2016	Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians.	BCL10
26767426	10.1016/j.jid.2015.12.027	2016	MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation.	BCL10
26771713	10.1080/15384101.2015.1121322	2016	BCL10 is recruited to sites of DNA damage to facilitate DNA double-strand break repair.	BCL10
26774590	10.1016/j.clim.2016.01.003	2016	Actin polymerisation after FCγR stimulation of human fibroblasts is BCL10 independent.	BCL10
26776161	10.1038/onc.2015.493	2016	Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.	BCL10
26884334	10.1074/jbc.M116.717322	2016	Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain.	BCL10
26936881	10.4049/jimmunol.1403165	2016	Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCβ Kinase Activity.	BCL10
26947079	10.1016/j.celrep.2016.02.031	2016	CARMA3 Is a Host Factor Regulating the Balance of Inflammatory and Antiviral Responses against Viral Infection.	BCL10
27006117	10.1242/jcs.185025	2016	The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling.	BCL10
27070692	10.1016/j.ccell.2016.03.018	2016	Killing Lymphoma with Smac-Mimetics: As Easy as ABC?	BCL10
27070702	10.1016/j.ccell.2016.03.006	2016	Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.	BCL10
27071417	10.1042/BCJ20160270	2016	Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.	BCL10
27092298	10.3389/fcimb.2016.00039	2016	Mechanistic Insights into the Role of C-Type Lectin Receptor/CARD9 Signaling in Human Antifungal Immunity.	BCL10
27109639	10.1016/j.clim.2016.04.011	2016	Successful clinical treatment and functional immunological normalization of human MALT1 deficiency following hematopoietic stem cell transplantation.	BCL10
27113748	10.15252/embr.201642109	2016	The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.	BCL10
27135977	10.1097/MOH.0000000000000257	2016	Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.	BCL10
27452667	10.1016/j.semcancer.2016.07.003	2016	MALT lymphoma: A paradigm of NF-κB dysregulation.	BCL10
27509941		2016	E1/E2 of Hepatitis C Virus Genotype4 and Apoptosis.	BCL10
27566587	10.18632/oncotarget.11548	2016	Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.	BCL10
27681433	10.1016/j.celrep.2016.08.080	2016	MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage.	BCL10
27777308	10.1074/jbc.M116.754028	2016	Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.	BCL10
24681956	10.1038/onc.2014.43	2015	B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.	BCL10
25391967	10.1007/s11060-014-1655-3	2015	Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.	BCL10
25556945	10.1016/j.chembiol.2014.10.021	2015	Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas.	BCL10
25569716	10.1038/ncomms6908	2015	Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma.	BCL10
25736751	10.1007/978-1-4939-2422-6_12	2015	Visualizing TCR-induced POLKADOTS formation and NF-κB activation in the D10 T-cell clone and mouse primary effector T cells.	BCL10
25748427	10.1371/journal.pone.0119363	2015	MALT1-ubiquitination triggers non-genomic NF-κB/IKK signaling upon platelet activation.	BCL10
25849213	10.1371/journal.pone.0122365	2015	Functional characterization of zebrafish (Danio rerio) Bcl10.	BCL10
25956014	10.1016/j.jaci.2015.02.037	2015	Advances in basic and clinical immunology in 2014.	BCL10
25965667	10.1371/journal.pone.0127083	2015	MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses.	BCL10
25973362	10.1016/j.fob.2015.04.011	2015	Oligomerized CARD16 promotes caspase-1 assembly and IL-1β processing.	BCL10
26038114	10.15252/msb.20145880	2015	Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation.	BCL10
26043155	10.1080/15548627.2015.1055439	2015	TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.	BCL10
26202083	10.3892/ijmm.2015.2290	2015	Bcl10 crucially nucleates the pro-apoptotic complexes comprising PDK1, PKCζ and caspase-3 at the nuclear envelope of etoposide-treated human cervical carcinoma C4-I cells.	BCL10
26277595	10.1016/j.jaci.2015.06.031	2015	Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.	BCL10
26287604	10.18632/oncotarget.4467	2015	Immunodeficiency and CARD-BCL10-MALT1.	BCL10
26525107	10.1038/ncomms9777	2015	The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.	BCL10
26615705	10.1016/j.anndiagpath.2015.10.001	2015	Antisecretory medication is associated with decreased Helicobacter pylori detection in gastric marginal zone lymphoma.	BCL10
26668357	10.1073/pnas.1507459112	2015	Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.	BCL10
26711259	10.1128/MCB.00876-15	2015	Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181.	BCL10
23846624	10.14670/HH-29.77	2014	BCL10 expression and localization in ocular adnexa MALT lymphomas: a comparative cytogenetic and immunohistochemical study.	BCL10
23886693	10.1016/j.imbio.2013.06.013	2014	Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages.	BCL10
24329526	10.1089/dna.2013.2199	2014	The TCR γδ repertoire and relative gene expression characteristics of T-ALL cases with biclonal malignant Vδ1 and Vδ2 T cells.	BCL10
24375035	10.1002/jcp.24543	2014	The three CARMA sisters: so different, so similar: a portrait of the three CARMA proteins and their involvement in human disorders.	BCL10
24383645	10.1111/imm.12207	2014	N-Ethyl-N-nitrosourea mutagenesis in the mouse provides strong genetic and in vivo evidence for the role of the Caspase Recruitment Domain (CARD) of CARD-MAGUK1 in T regulatory cell development.	BCL10
24411492	10.1016/j.cytogfr.2013.12.008	2014	The CBM signalosome: potential therapeutic target for aggressive lymphoma?	BCL10
24443940	10.1111/cei.12275	2014	CARD11 blockade suppresses murine collagen-induced arthritis via inhibiting CARD11/Bcl10 assembly and T helper type 17 response.	BCL10
24491438	10.1158/2159-8290.CD-13-0915	2014	Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.	BCL10
24497531	10.1182/blood-2013-05-504019	2014	A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells.	BCL10
24548923	10.1016/j.molimm.2014.01.011	2014	Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-κB induction and cytokine production.	BCL10
24560716	10.1016/j.imlet.2014.02.002	2014	1999-2014: 15 years of BCL10.	BCL10
24633921	10.1007/s13277-014-1791-6	2014	CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion.	BCL10
24641824	10.1016/j.bbagen.2014.03.011	2014	Degraded λ-carrageenan activates NF-κB and AP-1 pathways in macrophages and enhances LPS-induced TNF-α secretion through AP-1.	BCL10
24702227	10.3109/00016489.2013.878474	2014	Increased expression of Dec-205, Bcl-10, Tim-3, and Trem-1 mRNA in chronic otitis media with cholesteatoma.	BCL10
24732096	10.4161/cc.28707	2014	BCL10 regulates RNF8/RNF168-mediated ubiquitination in the DNA damage response.	BCL10
24777530	10.1038/ni.2888	2014	Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1β production.	BCL10
24792914	10.1016/j.immuni.2014.04.007	2014	Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation.	BCL10
24806599	10.1038/ncomms4755	2014	An ITAM-Syk-CARD9 signalling axis triggers contact hypersensitivity by stimulating IL-1 production in dendritic cells.	BCL10
24825920	10.1126/scisignal.2004882	2014	T cell receptor signals to NF-κB are transmitted by a cytosolic p62-Bcl10-Malt1-IKK signalosome.	BCL10
24917592	10.1126/scisignal.2005169	2014	T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.	BCL10
24958727	10.1074/jbc.M114.588723	2014	The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli.	BCL10
25011391	10.1007/s00418-014-1244-8	2014	Combining immunofluorescence with in situ proximity ligation assay: a novel imaging approach to monitor protein-protein interactions in relation to subcellular localization.	BCL10
25087226	10.1016/j.jaci.2014.06.015	2014	The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.	BCL10
25105596	10.1371/journal.pone.0103774	2014	MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.	BCL10
25150998	10.1007/978-1-4939-1212-4_8	2014	Detection of NF-κB pathway activation in T helper cells.	BCL10
25185127	10.1161/HYPERTENSIONAHA.114.03900	2014	Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodeling.	BCL10
25185129	10.1161/HYPERTENSIONAHA.114.04047	2014	Linking angiotensin II to nuclear factor-κ light chain enhancer of activated B cells-induced cardiovascular damage: bad CARMAs.	BCL10
25190756	10.1182/blood-2014-03-564609	2014	Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap-/- mice.	BCL10
25202022	10.1074/jbc.M114.588574	2014	C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-κB activation.	BCL10
25245034	10.1186/s12964-014-0049-7	2014	AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation.	BCL10
25320244	10.1182/blood-2014-07-589689	2014	Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.	BCL10
25365219	10.1172/JCI77493	2014	Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity.	BCL10
25384343	10.1186/s40001-014-0062-8	2014	Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.	BCL10
25536807	10.2298/vsp130813035h	2014	BCL10 aberations and NF-kappa B activation involving p65 are absent or rare in primary gastric MALT lymphoma.	BCL10
23149938	10.1128/MCB.00850-12	2013	A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival.	BCL10
23252516	10.1111/bjh.12172	2013	Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression.	BCL10
23297344	10.1128/MCB.06407-11	2013	Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.	BCL10
23393199	10.1158/0008-5472.CAN-12-2362	2013	Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.	BCL10
23463379	10.1002/ijc.28148	2013	Ca2+/calmodulin-dependent kinase II contributes to inhibitor of nuclear factor-kappa B kinase complex activation in Helicobacter pylori infection.	BCL10
23525237	10.3892/ijmm.2013.1307	2013	Self-oligomerization of the CARD domain prevents complex formation in the CARMA1 signalosome.	BCL10
23530562	10.1111/pin.12045	2013	BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens.	BCL10
23545653	10.1107/S1744309113005642	2013	Crystallization and preliminary X-ray crystallographic studies of the CARD domain of human CARMA1.	BCL10
23616440	10.1002/glia.22502	2013	Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB.	BCL10
23632891	10.1182/blood-2012-12-470153	2013	Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-κB activation in diffuse large B-cell lymphoma.	BCL10
23661444	10.4238/2013.April.12.6	2013	Significance of Bcl10 gene mutations in the clinical diagnosis of MALT-type ocular adnexal lymphoma in the Chinese population.	BCL10
23677497	10.1007/s13105-013-0259-2	2013	Bcl10 is an essential regulator for A20 gene expression.	BCL10
23690623	10.1073/pnas.1221925110	2013	Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex.	BCL10
23766559	10.1155/2013/397642	2013	Carrageenan-induced colonic inflammation is reduced in Bcl10 null mice and increased in IL-10-deficient mice.	BCL10
23770291	10.1016/j.cellsig.2013.06.007	2013	Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.	BCL10
23784377	10.1093/hmg/ddt286	2013	An association study of TOLL and CARD with leprosy susceptibility in Chinese population.	BCL10
23827971	10.1016/j.pneurobio.2013.06.002	2013	Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.	BCL10
23918355	10.1073/pnas.1303669110	2013	Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.	BCL10
24004675	10.1158/1078-0432.CCR-12-3869	2013	Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.	BCL10
24036998	10.1038/ni.2708	2013	Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells.	BCL10
24074955	10.1016/j.molcel.2013.08.032	2013	Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.	BCL10
24145781	10.1038/ni.2737	2013	ADAPted secretion of cytokines in NK cells.	BCL10
21954216	10.1002/pbc.23331	2012	Inhibition of caspase-8 activity caused by overexpression of BCL10 contributes to the pathogenesis of high-grade MALT lymphoma.	BCL10
21988643	10.3109/10428194.2011.631157	2012	Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type.	BCL10
22079206	10.1016/j.jnutbio.2011.05.012	2012	Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B.	BCL10
22323537	10.4049/jimmunol.1101502	2012	Cutting edge: the death adaptor CRADD/RAIDD targets BCL10 and suppresses agonist-induced cytokine expression in T lymphocytes.	BCL10
22363141	10.3748/wjg.v18.i7.685	2012	Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective.	BCL10
22366302	10.1016/j.jmb.2012.02.018	2012	Structural determinants of MALT1 protease activity.	BCL10
22382892	10.1038/leu.2012.28	2012	Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment.	BCL10
22407319	10.1038/nature10894	2012	The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response.	BCL10
22423967	10.1016/j.chom.2012.01.019	2012	The autophagy regulator Rubicon is a feedback inhibitor of CARD9-mediated host innate immunity.	BCL10
22474286	10.1074/jbc.M111.291708	2012	Forkhead transcription factor FOXO3a protein activates nuclear factor κB through B-cell lymphoma/leukemia 10 (BCL10) protein and promotes tumor cell survival in serum deprivation.	BCL10
22528498	10.1074/jbc.M111.335463	2012	Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome.	BCL10
22564715	10.1016/j.ygyno.2012.04.047	2012	Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.	BCL10
22574776	10.1042/BJ20120414	2012	Protease activity of MALT1: a mystery unravelled.	BCL10
22579587	10.1016/j.bbadis.2012.05.001	2012	Prolongation of carrageenan-induced inflammation in human colonic epithelial cells by activation of an NFκB-BCL10 loop.	BCL10
22658522	10.1016/j.immuni.2012.04.008	2012	Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-κB.	BCL10
22708078	10.1016/j.celrep.2012.04.006	2012	Bcl10 links saturated fat overnutrition with hepatocellular NF-kB activation and insulin resistance.	BCL10
22734454	10.3109/10520295.2012.695025	2012	BCL10 expression is unrelated to clinico-pathological parameters or prognoses for oral squamous cell carcinomas.	BCL10
22812606	10.1021/pr3000464	2012	Role-shifting PKCζ fosters its own proapoptotic destruction by complexing with Bcl10 at the nuclear envelope of human cervical carcinoma cells: a proteomic and biochemical study.	BCL10
22818167	10.1016/j.humpath.2012.03.024	2012	BCL10 down-regulation in peripheral T-cell lymphomas.	BCL10
22842723	10.3892/or.2012.1942	2012	Breast MALT lymphomas: a clinicopathological and cytogenetic study of 9 cases.	BCL10
22880103	10.1371/journal.pone.0042775	2012	Structural insights into the assembly of CARMA1 and BCL10.	BCL10
23035874	10.1186/1423-0127-19-85	2012	BCL10GFP fusion protein as a substrate for analysis of determinants required for mucosa-associated lymphoid tissue 1 (MALT1)-mediated cleavage.	BCL10
23087406	10.4049/jimmunol.1102952	2012	Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells.	BCL10
23153494	10.1016/j.devcel.2012.09.021	2012	The NF-κB signaling protein Bcl10 regulates actin dynamics by controlling AP1 and OCRL-bearing vesicles.	BCL10
23238011	10.1016/j.ccr.2012.11.011	2012	A new brew of MALT1 inhibitors.	BCL10
20830719	10.1002/ijc.25663	2011	BCL6 gene rearrangement and protein expression are associated with large cell presentation of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.	BCL10
21187856	10.1038/cr.2010.182	2011	NF-κB signaling pathways regulated by CARMA family of scaffold proteins.	BCL10
21199863	10.1074/jbc.M110.155895	2011	The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.	BCL10
21261681	10.1111/j.1365-2559.2010.03699.x	2011	MALT lymphoma: many roads lead to nuclear factor-κb activation.	BCL10
21283787	10.1371/journal.ppat.1001259	2011	Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2.	BCL10
21396111	10.1186/1478-811X-9-6	2011	B cell antigen receptor-induced activation of an IRAK4-dependent signaling pathway revealed by a MALT1-IRAK4 double knockout mouse model.	BCL10
21406399	10.1158/0008-5472.CAN-10-3626	2011	CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.	BCL10
21489413	10.1016/j.cellimm.2011.03.025	2011	CD4 ligation excludes the Carma1-Bcl10-MALT1 complex from GM1-positive membrane rafts in CD3/CD28 activated T cells.	BCL10
21513986	10.1016/j.molimm.2011.03.020	2011	CaMKII targets Bcl10 in T-cell receptor induced activation of NF-κB.	BCL10
21674474	10.1002/eji.201041052	2011	Dephosphorylation of Bcl-10 by calcineurin is essential for canonical NF-κB activation in Th cells.	BCL10
21700900	10.1152/ajpgi.00071.2011	2011	Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-κB activation following carrageenan.	BCL10
21745165	10.3109/10428194.2011.596968	2011	Thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a clinicopathological and genetic analysis of six cases.	BCL10
21750409	10.4161/cc.10.15.16923	2011	From MALT lymphoma to the CBM signalosome: three decades of discovery.	BCL10
21837708	10.1002/gcc.20910	2011	Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphoma.	BCL10
21862580	10.1074/jbc.M111.259549	2011	Akt fine-tunes NF-κB-dependent gene expression during T cell activation.	BCL10
21896478	10.1074/jbc.M111.263384	2011	The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.	BCL10
22158899	10.1073/pnas.1111708108	2011	Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region.	BCL10
19714753	10.1002/ibd.21092	2010	Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent.	BCL10
19864123	10.1016/j.jnutbio.2009.07.002	2010	Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds.	BCL10
19897484	10.1074/jbc.M109.050815	2010	B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.	BCL10
19950170	10.1002/eji.200939445	2010	c-Rel phenocopies PKCtheta but not Bcl-10 in regulating CD8+ T-cell activation versus tolerance.	BCL10
20193035	10.1111/j.1744-313X.2010.00898.x	2010	BCL10 as a new candidate gene for immune response in pigs: cloning, expression and association analysis.	BCL10
20235165	10.1002/path.2699	2010	Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.	BCL10
20439115	10.1016/j.molimm.2010.04.005	2010	Interaction of calmodulin with Bcl10 modulates NF-kappaB activation.	BCL10
20466000	10.1016/j.yexcr.2010.05.004	2010	Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations.	BCL10
20507572	10.1186/1471-2172-11-26	2010	Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells.	BCL10
20516126	10.1101/cshperspect.a000109	2010	Oncogenic activation of NF-kappaB.	BCL10
20520640	10.1038/leu.2010.118	2010	Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.	BCL10
20538615	10.1074/jbc.M110.131300	2010	CARD9 mediates dectin-2-induced IkappaBalpha kinase ubiquitination leading to activation of NF-kappaB in response to stimulation by the hyphal form of Candida albicans.	BCL10
20551178	10.1242/jcs.069476	2010	Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.	BCL10
20605784	10.1074/jbc.C110.109421	2010	The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.	BCL10
20679053		2010	[Orbital and ocular adnexal lymphomas. Clinico-pathological correlation in 25 cases].	BCL10
20685844	10.1101/cshperspect.a003004	2010	Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.	BCL10
20799731	10.1021/bi101052d	2010	Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain.	BCL10
20937806	10.1074/jbc.M110.159681	2010	Tumor necrosis factor alpha-induced inflammation is increased but apoptosis is inhibited by common food additive carrageenan.	BCL10
21041303	10.1074/jbc.M110.158949	2010	Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.	BCL10
21084243	10.1684/bdc.2010.1214	2010	[Molecular abnormalities in lymphomas].	BCL10
22282688	10.2147/JBM.S9772	2010	L-CBM signaling in lymphocyte development and function.	BCL10
18775860	10.1167/iovs.08-2539	2009	Extranodal marginal zone lymphoma in the ocular region: clinical, immunophenotypical, and cytogenetical characteristics.	BCL10
18952491	10.1016/j.oraloncology.2008.08.003	2009	Expression of BCL10 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.	BCL10
19066953	10.1007/s00428-008-0710-x	2009	The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.	BCL10
19085995	10.1002/ibd.20821	2009	ROS, Hsp27, and IKKbeta mediate dextran sodium sulfate (DSS) activation of IkappaBa, NFkappaB, and IL-8.	BCL10
19112107	10.1074/jbc.C800207200	2009	CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex.	BCL10
19118383	10.1038/nature07613	2009	Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival.	BCL10
19124758	10.4049/jimmunol.182.2.1146	2009	Differential use of CARD9 by dectin-1 in macrophages and dendritic cells.	BCL10
19136564	10.1074/jbc.M806650200	2009	Phospholipase Cgamma2 is critical for Dectin-1-mediated Ca2+ flux and cytokine production in dendritic cells.	BCL10
19139169	10.1084/jem.20081445	2009	Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation.	BCL10
19144384	10.1016/j.humpath.2008.06.032	2009	BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome.	BCL10
19279678	10.1371/journal.pone.0004822	2009	Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.	BCL10
19298243	10.1111/j.1600-0714.2009.00757.x	2009	Nuclear BCL10 in primary Sjögren's syndrome.	BCL10
19309400	10.1111/j.1365-2559.2009.03250.x	2009	Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome.	BCL10
19336552	10.1158/1055-9965.EPI-08-1037	2009	Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.	BCL10
19359218	10.1016/j.it.2009.03.002	2009	CARD9 versus CARMA1 in innate and adaptive immunity.	BCL10
19366357	10.1111/j.1747-0285.2009.00805.x	2009	Protein-protein interactions: a simple strategy to identify binding sites and peptide antagonists.	BCL10
19385974	10.1111/j.1349-7006.2009.01139.x	2009	Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.	BCL10
19428562	10.1016/j.imlet.2009.03.005	2009	Barley-derived beta-D-glucan induces immunostimulation via a dectin-1-mediated pathway.	BCL10
19444310	10.1038/embor.2009.64	2009	COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation.	BCL10
19454668	10.4049/jimmunol.0900498	2009	CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells.	BCL10
19480824	10.1051/medsci/2009255454	2009	[Role of CK1alpha in adaptive immunity and lymphomagenesis].	BCL10
19494296	10.4049/jimmunol.0803313	2009	A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.	BCL10
19535128	10.1016/j.humpath.2009.02.018	2009	Primary mucosa-associated lymphoid tissue lymphoma of the gallbladder: report of a case harboring API2/MALT1 gene fusion.	BCL10
19538180	10.1042/BJ20090055	2009	Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.	BCL10
19573080	10.1111/j.1365-2141.2009.07790.x	2009	Common genetic variants in candidate genes and risk of familial lymphoid malignancies.	BCL10
19576081		2009	[A clinical study of chromosome translocations in extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in Chinese patients].	BCL10
19608748	10.1182/blood-2009-03-208215	2009	Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B-cell lymphoma.	BCL10
19690445	10.1159/000235603	2009	BCL10 single nucleotide polymorphism and its association with CSF dissemination of primary intracranial germ cell tumors.	BCL10
19696203	10.1182/blood-2008-12-192583	2009	Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.	BCL10
19709433	10.1186/1476-4598-8-67	2009	STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.	BCL10
19773279	10.1136/oem.2008.044024	2009	Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity.	BCL10
19841089	10.1084/jem.20091167	2009	Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.	BCL10
19860212		2009	[Crucial roles of Helicobacter pylori infection in the pathogenesis of gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma].	BCL10
19897720	10.1073/pnas.0907511106	2009	Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma.	BCL10
19915361		2009	[Recent progress in lymphoma genomics and biology].	BCL10
20431728	10.5009/gnl.2009.3.2.81	2009	Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis.	BCL10
20695076	10.4248/IJOS.09059	2009	CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex.	BCL10
17893875	10.1002/ijc.23071	2008	Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype.	BCL10
18175935	10.1248/bpb.31.13	2008	Dissociation of Toll-like receptor 2-mediated innate immune response to Zymosan by organic solvent-treatment without loss of Dectin-1 reactivity.	BCL10
18192506	10.1182/blood-2007-11-123513	2008	Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.	BCL10
18223652	10.1038/ni1561	2008	T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20.	BCL10
18227156	10.1128/MCB.01505-07	2008	T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b.	BCL10
18231929	10.1080/10428190701784722	2008	Analysis of CARMA1/BCL10/MALT1 expression in Reed-Sternberg cells of classical Hodgkin lymphoma.	BCL10
18245662	10.3324/haematol.11950	2008	Rare occurrence of IgVH gene translocations and restricted IgVH gene repertoire in ocular MALT-type lymphoma.	BCL10
18252714	10.1074/jbc.M708833200	2008	Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells.	BCL10
18264101	10.1038/ni1568	2008	The proteolytic activity of the paracaspase MALT1 is key in T cell activation.	BCL10
18287044	10.1073/pnas.0712313105	2008	NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation.	BCL10
18316375	10.1074/jbc.M707988200	2008	Sequestration of NF-kappaB signaling complexes in lipid rafts contributes to repression of NF-kappaB in T lymphocytes under hyperthermia stress.	BCL10
18349075	10.1242/jcs.021105	2008	A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB.	BCL10
18445693	10.1158/1078-0432.CCR-07-4946	2008	Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.	BCL10
18452717	10.1016/j.bbagen.2008.03.019	2008	Carrageenan-induced NFkappaB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10.	BCL10
18550498	10.3724/sp.j.1005.2008.00747	2008	[In silico identification, molecular cloning and verification of a novel pig gene homologous to human BCL10 of innate immunity and its preliminary expression profiles in pigs].	BCL10
18575460	10.1038/nri2338	2008	Multifunctional roles for MALT1 in T-cell activation.	BCL10
18583339	10.1074/jbc.M802344200	2008	T cell receptor-mediated activation of CD4+CD44hi T cells bypasses Bcl10: an implication of differential NF-kappaB dependence of naïve and memory T cells during T cell receptor-mediated responses.	BCL10
18606643	10.4049/jimmunol.181.2.918	2008	Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9.	BCL10
18625728	10.1128/MCB.00418-08	2008	The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.	BCL10
18628489	10.1182/blood-2008-02-137513	2008	Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma.	BCL10
18718996	10.1152/ajpgi.90434.2008	2008	Lipopolysaccharide activates NF-kappaB by TLR4-Bcl10-dependent and independent pathways in colonic epithelial cells.	BCL10
18802088	10.4049/jimmunol.181.7.4840	2008	Distinct regulation of integrin-dependent T cell conjugate formation and NF-kappa B activation by the adapter protein ADAP.	BCL10
18806265	10.1074/jbc.M800670200	2008	Multiple protein domains mediate interaction between Bcl10 and MALT1.	BCL10
18829987	10.1093/intimm/dxn108	2008	CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.	BCL10
18833938		2008	[Molecular genetics in primary gastrointestinal lymphomas].	BCL10
18927281	10.1158/1078-0432.CCR-08-0702	2008	Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3.	BCL10
18941215	10.4049/jimmunol.181.9.6244	2008	Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.	BCL10
18949449	10.1007/s12185-008-0187-z	2008	BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma.	BCL10
19035248		2008	[Abnormal BCL10 nuclear expression and chromosomal translocation in ocular adnexal mucosa-associated lymphoid tissue lymphomas].	BCL10
19080537		2008	[High incidence of t (11; 18)/API2-MALT1 and BCL10 aberrant nuclear expression in pulmonary mucosa-associated lymphoid tissue lymphomas].	BCL10
19174606	10.1159/000195698	2008	Methylation of p16INK4A and mitotic arrest defective protein 2 (MAD2) genes in gastric marginal-zone B-cell lymphomas.	BCL10
17052756	10.1016/j.molimm.2006.09.012	2007	Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II.	BCL10
17095601	10.1073/pnas.0608388103	2007	Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production.	BCL10
17095757	10.1152/ajpgi.00380.2006	2007	Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells.	BCL10
17098884	10.1136/jcp.2006.041012	2007	Pulmonary mucosa-associated lymphoid tissue lymphoma with strong nuclear B-cell CLL/lymphoma 10 (BCL10) expression and novel translocation t(1;2)(p22;p12)/immunoglobulin kappa chain-BCL10.	BCL10
17101977	10.1073/pnas.0601947103	2007	CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.	BCL10
17167822	10.1002/path.2117	2007	Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.	BCL10
17179215	10.1073/pnas.0601894104	2007	Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors.	BCL10
17182539	10.4049/jimmunol.178.1.49	2007	B cell lymphoma 10 is essential for FcepsilonR-mediated degranulation and IL-6 production in mast cells.	BCL10
17199743	10.1111/j.1440-1827.2007.02056.x	2007	MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.	BCL10
17202357	10.4049/jimmunol.178.2.953	2007	Bcl10/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection.	BCL10
17213322	10.1073/pnas.0606982104	2007	Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.	BCL10
17287209	10.1074/jbc.M611038200	2007	A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.	BCL10
17317796	10.1354/vp.44-2-196	2007	High-throughput immunophenotyping of 43 ferret lymphomas using tissue microarray technology.	BCL10
17356384	10.1097/01.jnen.0000248553.45456.96	2007	Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression.	BCL10
17363905	10.1038/sj.emboj.7601622	2007	Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways.	BCL10
17371994	10.4049/jimmunol.178.7.4373	2007	Bcl10 controls TCR- and FcgammaR-induced actin polymerization.	BCL10
17433222	10.1051/medsci/2007234353	2007	[New Bcl10 regulation mechanisms: a step in the comprehension of what has occurred in MALT lymphomas?].	BCL10
17438001	10.1101/gad.1502507	2007	CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation.	BCL10
17462996	10.1074/jbc.M610610200	2007	Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation.	BCL10
17468049	10.1016/j.it.2007.04.004	2007	Post-translational modifications regulate distinct functions of CARMA1 and BCL10.	BCL10
17473310	10.1126/stke.3842007pe21	2007	CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.	BCL10
17478723	10.1126/science.1137895	2007	Regulation of NF-kappaB activation in T cells via association of the adapter proteins ADAP and CARMA1.	BCL10
17502353	10.1128/MCB.01645-06	2007	Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation.	BCL10
17525089	10.1136/gut.2007.123729	2007	Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation.	BCL10
17540779	10.1152/ajpgi.00149.2007	2007	Bcl10 mediates LPS-induced activation of NF-kappaB and IL-8 in human intestinal epithelial cells.	BCL10
17613665	10.1080/15321810701454573	2007	Development, evaluation, and application of a highly sensitive microtiter plate ELISA for human Bcl10 protein.	BCL10
17660823	10.1038/ni1493	2007	MALT1 directs B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit.	BCL10
17785812	10.4049/jimmunol.179.6.3752	2007	Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation.	BCL10
17845767		2007	[Detection of t (11; 18) and rearrangement of bcl-10 in paraffin-embedded samples using interphase fluorescence in-situ hybridization].	BCL10
17852708	10.1080/10428190701606818	2007	Higher rates of t(11;18) in Chinese patients with transformed type of MALT lymphoma suggest novel pathways for progression of the disease.	BCL10
17948050	10.1038/sj.emboj.7601897	2007	Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.	BCL10
18040143	10.3960/jslrt.47.31	2007	MALT lymphoma : recent advances in aetiology and molecular genetics.	BCL10
18086859	10.1084/jem.20070379	2007	IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells.	BCL10
18307876		2007	[Clonal relationship between transformed and non-transformed components in mucosa-associated lymphoid tissue lymphoma].	BCL10
18307945		2007	[Significance of detection of Bcl-10 novel mutation in ocular adnexal mucosa-associated lymphoid tissue lymphoma].	BCL10
18346354		2007	[Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].	BCL10
16229939	10.1016/j.canlet.2005.08.019	2006	Association of BCL10 germ line polymorphisms on chromosome 1p with advanced stage testicular germ cell tumor patients.	BCL10
16280327	10.1074/jbc.M511014200	2006	A pathway for tumor necrosis factor-alpha-induced Bcl10 nuclear translocation. Bcl10 is up-regulated by NF-kappaB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus.	BCL10
16323006	10.1007/s00428-005-0122-0	2006	Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.	BCL10
16341151	10.1038/modpathol.3800523	2006	MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells.	BCL10
16344587	10.1136/gut.2005.081117	2006	Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication.	BCL10
16395405	10.1172/JCI25641	2006	cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas.	BCL10
16432253	10.1084/jem.20051982	2006	The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation.	BCL10
16495340	10.1091/mbc.e05-10-0985	2006	POLKADOTS are foci of functional interactions in T-Cell receptor-mediated signaling to NF-kappaB.	BCL10
16508008	10.1128/MCB.26.6.2327-2336.2006	2006	CARMA1 is required for Akt-mediated NF-kappaB activation in T cells.	BCL10
16512826	10.1111/j.1365-2141.2006.05969.x	2006	Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21).	BCL10
16572121	10.1038/nature04687	2006	A loss-of-function RNA interference screen for molecular targets in cancer.	BCL10
16572204	10.1038/sj.leu.2404192	2006	Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.	BCL10
16636337	10.1200/JCO.2006.05.6150	2006	Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.	BCL10
16636680	10.1038/modpathol.3800609	2006	Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation.	BCL10
16648871	10.1038/modpathol.3800597	2006	Nuclear bcl10 expression characterizes a group of ocular adnexa MALT lymphomas with shorter failure-free survival.	BCL10
16672958	10.1038/441032a	2006	Cell biology: divining cancer cell weaknesses.	BCL10
16775419	10.4161/cc.5.13.2866	2006	CIAP2 inhibits anigen receptor signaling by targeting Bcl10 for degredation.	BCL10
16776985		2006	[Mucosa-associated lymphoid tissue lymphoma].	BCL10
16784987	10.1016/j.humpath.2006.02.012	2006	Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma.	BCL10
16785131		2006	BCL10 gene amplification associated with strong nuclear BCL10 expression in a diffuse large B cell lymphoma with IGH-BCL2 fusion.	BCL10
16799010	10.1167/iovs.05-1312	2006	Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma.	BCL10
16809782	10.1128/MCB.02469-05	2006	Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation.	BCL10
16818229	10.1016/j.molcel.2006.05.027	2006	Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation.	BCL10
16830336	10.1002/gcc.20352	2006	Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas.	BCL10
16831874	10.1074/jbc.M513057200	2006	The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4.	BCL10
16862125	10.1038/nature04926	2006	Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity.	BCL10
16863911	10.1016/j.exphem.2006.06.003	2006	The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics.	BCL10
16917511	10.1038/modpathol.3800668	2006	MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast.	BCL10
16920630	10.1016/j.cub.2006.06.062	2006	Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation.	BCL10
17043017		2006	CARMA1 and chromosomal translocations in extranodal marginal zone B-cell lymphomas of MALT type or diffuse large B-cell lymphomas.	BCL10
17073595	10.2174/138945006778559256	2006	The Bcl10/Malt1 signaling pathway as a drug target in lymphoma.	BCL10
17099876	10.1002/cncr.22326	2006	Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.	BCL10
17122510	10.1097/01.pas.0000213275.60962.2a	2006	The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.	BCL10
17274374		2006	[Expression of BCL-10 protein and the relationship with API2-MALT1 fusion gene in extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue].	BCL10
15598810	10.1182/blood-2004-06-2297	2005	MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.	BCL10
15682432	10.1002/path.1711	2005	FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma.	BCL10
15682443	10.1002/path.1715	2005	MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.	BCL10
15694184	10.1016/j.beha.2004.08.003	2005	Update on MALT lymphomas.	BCL10
15703784	10.1038/sj.leu.2403644	2005	T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma.	BCL10
15711920	10.1007/s10495-005-6059-6	2005	Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.	BCL10
15802594	10.1126/science.1110902	2005	Cell biology. Kinasing and clipping down the NF-kappa B trail.	BCL10
15802604	10.1126/science.1107107	2005	PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.	BCL10
15845895	10.1182/blood-2005-01-0004	2005	Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21).	BCL10
15878976	10.1182/blood-2004-04-1248	2005	Bcl10 can promote survival of antigen-stimulated B lymphocytes.	BCL10
15989914	10.1016/j.amjmed.2005.02.004	2005	Idiopathic retroperitoneal fibrosis associated with immunohematological abnormalities.	BCL10
16123224	10.1182/blood-2004-12-4785	2005	MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10.	BCL10
16127295	10.1159/000086789	2005	Accumulation of BCL10 at the perinuclear region is required for the BCL10-mediated nuclear factor-kappa B activation.	BCL10
16155022	10.1200/JCO.2005.05.011	2005	Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma.	BCL10
16177990	10.1002/cncr.21421	2005	Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma.	BCL10
16310461	10.1016/j.ajo.2005.05.038	2005	BCL10 expression in ocular adnexal lymphomas.	BCL10
16440771		2005	[Long-term remission after CHOP therapy in a case of multifocal extranodal diffuse large B-cell lymphoma with t(1 ; 14) (p22 ; q32) and rearrangement of bcl-10].	BCL10
16545185		2005	[Expression of bcl-10 protein in MALT lymphoma].	BCL10
14574335	10.1038/sj.leu.2403185	2004	Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1.	BCL10
14638696	10.1074/jbc.C300460200	2004	Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation.	BCL10
14657271	10.1242/jcs.00904	2004	NF-kappaB signaling in lymphocytes: a new cast of characters.	BCL10
14673152	10.1128/MCB.24.1.164-171.2003	2004	CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1.	BCL10
14674990	10.1111/j.1440-1827.2004.01580.x	2004	No evidence of a correlation between BCL10 expression and API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma.	BCL10
14695475	10.1038/nature02273	2004	Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.	BCL10
14724296	10.1073/pnas.0307858100	2004	Complex and dynamic redistribution of NF-kappaB signaling intermediates in response to T cell receptor stimulation.	BCL10
14754896	10.1074/jbc.M310599200	2004	MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.	BCL10
14989765		2004	[Expression of t(11;18) and bcl-10 in gastrointestinal MALT lymphoma].	BCL10
15049289	10.1016/j.it.2003.12.007	2004	New roles for Bcl10 in B-cell development and LPS response.	BCL10
15070758	10.1073/pnas.0400885101	2004	Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation.	BCL10
15082780	10.1128/MCB.24.9.3860-3873.2004	2004	Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling.	BCL10
15100327	10.1093/jnci/djh138	2004	Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation.	BCL10
15122200	10.1038/nri1352	2004	CARMA1, BCL-10 and MALT1 in lymphocyte development and activation.	BCL10
15125833	10.1016/s1097-2765(04)00236-9	2004	The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.	BCL10
15143341	10.1038/modpathol.3800164	2004	t(1;14) and t(11;18) in the differential diagnosis of Waldenström's macroglobulinemia.	BCL10
15184390	10.1074/jbc.M402244200	2004	Physical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulator.	BCL10
15207693	10.1016/j.bbrc.2004.05.112	2004	Characterization of Bcl10 as a potential transcriptional activator that interacts with general transcription factor TFIIB.	BCL10
15210867	10.112/4.3.3	2004	Ubiquitination for activation: new directions in the NF-kappaB roadmap.	BCL10
15213237	10.1074/jbc.M400241200	2004	BCL10 mediates lipopolysaccharide/toll-like receptor-4 signaling through interaction with Pellino2.	BCL10
15337797	10.1200/JCO.2004.10.087	2004	Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.	BCL10
15539155	10.1016/j.immuni.2004.09.012	2004	SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1.	BCL10
15540895	10.1532/ijh97.04101	2004	Nuclear factor kappaB activation and antiapoptosis in mucosa-associated lymphoid tissue lymphoma.	BCL10
15541657	10.1016/j.smim.2004.08.022	2004	The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling.	BCL10
15577674	10.1097/00000478-200412000-00003	2004	Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion.	BCL10
15634591		2004	[Expression of BCL-10 in gastrointestinal mucosa-associated lymphoid tissue lymphoma].	BCL10
15637807	10.1016/j.febslet.2004.10.094	2004	Inhibition of Bcl10-mediated activation of NF-kappa B by BinCARD, a Bcl10-interacting CARD protein.	BCL10
12393483	10.1182/blood-2002-07-2009	2003	Cell cycle deregulation in B-cell lymphomas.	BCL10
12517817	10.1182/blood-2002-10-3167	2003	High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma.	BCL10
12589800	10.1016/s0006-291x(03)00063-9	2003	UV-light induces p38 MAPK-dependent phosphorylation of Bcl10.	BCL10
12651604	10.1016/S0002-9440(10)63908-9	2003	API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.	BCL10
12676782	10.1182/blood-2002-11-3502	2003	Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma.	BCL10
12692046	10.1136/gut.52.5.641	2003	Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas.	BCL10
12720128	10.1053/sonc.2003.50049	2003	Dysregulation of apoptosis in Waldenstrom's macroglobulinemia does not involve nuclear factor kappa B activation.	BCL10
12766579	10.1097/00000478-200306000-00006	2003	Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases.	BCL10
12835267	10.1093/bioinformatics/btg148	2003	Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values.	BCL10
12841349		2003	Bcl10 protein can act as a transcription activator in yeast.	BCL10
12867038	10.1016/s0960-9822(03)00491-3	2003	Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation.	BCL10
12883238	10.1097/00000478-200308000-00003	2003	Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases.	BCL10
12900354	10.1182/blood-2003-04-1286	2003	Aberrant BCL10 nuclear expression in nasal NK/T-cell lymphoma.	BCL10
12909454	10.1016/s1471-4906(03)00177-7	2003	TCR-induced NF-kappaB activation: a crucial role for Carma1, Bcl10 and MALT1.	BCL10
12910267	10.1038/ni963	2003	Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells.	BCL10
12950026	10.1002/path.1426	2003	Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.	BCL10
12960515	10.1097/00001622-200309000-00001	2003	Update: gastric MALT lymphoma.	BCL10
14502259	10.1038/sj.thj.6200295	2003	T(11;18)(q21;q21) in gastric MALT lymphoma and diffuse large B-cell lymphoma of Chinese patients.	BCL10
14523480	10.1038/sj.leu.2403128	2003	BCL10 mutations are irrelevant to its aberrant nuclear localization in nasal NK/T-cell lymphoma.	BCL10
14576442	10.1126/science.1090769	2003	Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.	BCL10
14614861	10.1016/s1074-7613(03)00293-0	2003	Differential requirement for Malt1 in T and B cell antigen receptor signaling.	BCL10
14634131	10.4049/jimmunol.171.11.6154	2003	Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation.	BCL10
14645834	10.1126/science.1092951	2003	Immunology. The paracaspase connection.	BCL10
14681324	10.1097/01.MP.0000097283.47637.58	2003	API2-MALT1 fusion gene in colorectal lymphoma.	BCL10
14716524	10.1007/s10120-003-0260-5	2003	Colliding gastric and intestinal phenotype well-differentiated adenocarcinoma of the stomach developing in an area of MALT-type lymphoma.	BCL10
15202520	10.1080/10428190310001623793	2003	Molecular pathogenesis of mucosal-associated lymphoid tissue (MALT) lymphoma.	BCL10
11748643	10.1002/path.1015	2002	BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.	BCL10
11753078	10.1097/00062752-200201000-00009	2002	Mucosa-associated lymphoid tissue lymphoma.	BCL10
11818074	10.1016/s0960-9822(01)00668-6	2002	Bcl10.	BCL10
11830492	10.1182/blood.v99.4.1398	2002	BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression.	BCL10
11836626		2002	Lack of Bcl10 mutations in malignant cartilaginous tumors.	BCL10
11850073	10.1016/s0165-4608(01)00548-9	2002	Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization.	BCL10
11960389	10.1038/sj.thj.6200146	2002	Genetic alterations underlying the pathogenesis of MALT lymphoma.	BCL10
12017308		2002	Lack of BCL10 mRNA mutation in lymphold malignancies.	BCL10
12091384	10.1074/jbc.M202222200	2002	Protein kinase C-associated kinase (PKK) mediates Bcl10-independent NF-kappa B activation induced by phorbol ester.	BCL10
12154356	10.1038/ni824	2002	A requirement for CARMA1 in TCR-induced NF-kappa B activation.	BCL10
12154360	10.1038/ni830	2002	CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation.	BCL10
12389689	10.1258/00222150260171605	2002	Lack of Bcl10 gene mutations in laryngeal squamous cell carcinoma.	BCL10
14993411	10.1124/mi.2.6.356	2002	Determining the destiny of NF-kappa B after TCR ligation: it's CARMA1.	BCL10
11163238	10.1016/s0092-8674(01)00189-1	2001	Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure.	BCL10
11238466	10.1083/jcb.152.5.1115	2001	Equine herpesvirus protein E10 induces membrane recruitment and phosphorylation of its cellular homologue, bcl-10.	BCL10
11259443	10.1074/jbc.M102488200	2001	Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B.	BCL10
11262391	10.1074/jbc.M009984200	2001	Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.	BCL10
11278692	10.1074/jbc.M010512200	2001	CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B.	BCL10
11356195	10.1016/s0014-5793(01)02414-0	2001	Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation.	BCL10
11387339	10.1074/jbc.M103824200	2001	Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction.	BCL10
11466612	10.1038/sj.onc.1204576	2001	Interchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis signaling.	BCL10
11605060	10.3892/or.8.6.1333	2001	Absence of Bcl10 gene mutations in Ewing's sarcomas.	BCL10
11707622	10.1097/00125480-200111000-00001	2001	Marginal-zone B-cell lymphoma of extranodal mucosa-associated lymphoid tissue type: molecular genetics provides new insights into pathogenesis.	BCL10
11722987	10.1182/asheducation-2001.1.241	2001	MALT Lymphomas.	BCL10
11780342		2001	bcl 10 gene mutation in hepatocellular carcinoma.	BCL10
10753917	10.1074/jbc.275.15.11114	2000	Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein.	BCL10
11021819	10.1016/S0002-9440(10)64630-5	2000	BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma.	BCL10
11053425	10.1074/jbc.C000726200	2000	CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B.	BCL10
11090634	10.1016/s1097-2765(00)00094-0	2000	Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma.	BCL10
11701542	10.1182/asheducation-2000.1.180	2000	Non-Hodgkin's Lymphoma: Molecular Features of B Cell Lymphoma.	BCL10
10187770	10.1074/jbc.274.15.9955	1999	CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10.	BCL10
10187771	10.1074/jbc.274.15.9962	1999	Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase.	BCL10
10187815	10.1074/jbc.274.15.10287	1999	mE10, a novel caspase recruitment domain-containing proapoptotic molecule.	BCL10
10364242	10.1074/jbc.274.25.17946	1999	CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis.	BCL10
10400625	10.1074/jbc.274.29.20127	1999	c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB.	BCL10
9989495	10.1016/s0092-8674(00)80957-5	1999	Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.	BCL10
